Literature DB >> 1949821

[Early summer meningoencephalitis vaccination, a preventive medicine measure with high acceptance in Austria].

C Kunz1, H Hofmann, H Dippe.   

Abstract

The vaccination against Tick-borne encephalitis (TBE) was accepted by the Austrian population on a broad scale. Of the estimated 5 million Austrians at risk of TBE, as of 1987 only 1.7 million were unvaccinated. From the very small number of TBE cases despite vaccination we were able to calculate a protection rate of 95% after 2 vaccinations and of 99% after 3 or more vaccinations. Since 1984 as a consequence of the vaccination campaign a steady decline of TBE could be observed in Austria. More than 10 years ago improved procedures enabled the production of a highly purified vaccine, thus reducing the number of side effects to a minimum. We here present data from 2067 vaccinees who reported on eventual side reactions by means of a questionnaire. The reactions reported did not exceed those which could be expected after application of a placebo vaccine. Due to high immunogenicity of the vaccine a booster effect can be achieved even some years after a missed vaccination, precluding the necessity of beginning a new series.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949821

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  3 in total

1.  First case of tick-borne encephalitis (TBE) in the Saarland.

Authors:  J Treib
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

Review 2.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Tick-borne encephalitis in Austria: incidence 1990 and 1991.

Authors:  C Vutuc; M Kunze
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.